There is interest in following up one of our aggressive members who, at the beginning of September, invested $500,000 in Novavax (NVAX) at $174.39 per share to allow her to sell covered calls on the shares.
Soon after, NVAX dropped to $92.90. Her loss, just over $200,000 exceeded the premium she received by a wide margin. However, she bought more NVAX, lowering her per share cost. Each Monday after that, she wrote more covered calls/cash- secured puts on it, receiving between $12,000 to $18,000 premium income each week.
What are her plans now?You need to login to view the rest of the content. Please Login. Not a Member? You can now sign up for a one-month free trial membership. Join Us